Tag: Atrial Fibrillation
Marine Omega-3 Fatty Acid, Vitamin D Do Not Cut Risk for A-Fib
Treatment with EPA-DHA or vitamin D3 supplement versus placebo results in no significant difference in incident atrial fibrillation over five years
Racial, Socioeconomic Disparities Seen in Atrial Fibrillation Treatment
Black, Latinx, and lower-income patients receive less rhythm control
American Indians Have Highest Risk for Nonhemorrhagic Stroke
American Indians have highest risk of nonhemorrhagic stroke compared with non-American Indians, in presence or absence of a-fib
Ablation Beats Drug Therapy for Women and Men With A-Fib
No significant difference seen in primary outcome of death, disabling stroke, serious bleeding, cardiac arrest for men, women
Genetic Data Suggest Increases in BP May Cause A-Fib
Causal relationship of BP and a-fib did not change when SNPs associated with possible confounders were excluded
Moderate Alcohol Consumption Does Not Up Stroke Risk in A-Fib
Risk for stroke or systemic embolism not increased with low-to-moderate drinking; no increased risk found for bleeding
Consuming Alcohol May Increase Risk for Atrial Fibrillation
Hazard ratio 1.16 for one drink per day; similar associations seen across types of alcohol
Heavy Alcohol Consumption Tied to Worse Atrial Fibrillation Outcomes
No similar effect seen for light or moderate alcohol consumption
AHA: Ablation Better Than Meds for Initial A-Fib Treatment
Findings based on randomized trial evaluating initial treatment with cryoballoon catheter ablation versus standard meds
ACR: Warfarin Tied to Increased Risk for Knee, Hip Replacement in OA
Among adults with atrial fibrillation, warfarin use linked to increased odds of knee, hip replacement versus direct oral anticoagulants
